Research Use Only · Dosing data compiled from published literature · Not for human or veterinary use

MOTS-c Dosage & Reconstitution

Mitochondrial ORF of the 12S rRNA type-c. Work out exactly what to draw for your own mix, see the doses used in research, and follow a week-by-week plan. Evidence tier: preclinical.

1Set Up Your Mix

13.333 mg/mL · 13333 mcg/mL

Your Answer — MOTS-c

40 mg in 3 mL
37.5Draw To This Line
0.375That's This Many mL
8Doses In The Vial
0102030405060708090100 U-100 syringe · 1 mL · 100 units draw to 37.5
40 mg ÷ 3 mL = 13.333 mg/mL  →  5 mg ÷ 13.333 mg/mL = 0.375 mL  →  × 100 = 37.5 units
Looks good. Draw to 37.5 units on a 1 mL syringe. That is an easy amount to measure, and this vial gives you 8 doses.
When to dose
Time of dayNo particular time of day has been established.
FoodNo fasting requirement has been established.

The studies behind this compound did not test timing or food state as variables, so we are not going to invent a rule. Pick a time you can keep to consistently.

2Week-By-Week Plan — MOTS-c

Two protocols — pick one, do not combine them
WhenDoseHow OftenHow Many mLDraw ToNumber Of DosesPeptide Used
Option A · once a week
a single 5 mg injection each week
5 mg once weekly 0.375 mL 37.5 u 1 5 mg
Option B · daily, 5 on 2 off
1 mg a day for five days, then two days off
1 mg 5× weekly 0.075 mL 7.5 u 5 5 mg
Time until the top dose
ongoing
Peptide used getting there
0 mg
Vials you'll need
— × 40 mg
Once you're at the top dose
5 mg / 4 wk · 0.13 vials
Where this plan came from
A published protocol
Where this came from: OptimalDosages protocol. These are alternatives, not a schedule to work through. Either take 5 mg once a week, or 1 mg a day on a five-days-on, two-days-off pattern — both come to about the same weekly total. Pick whichever suits you and stay on it.

3Common Doses — MOTS-c

worked out for your mix
LevelDoseHow OftenHow Many mLDraw ToDoses In Vial
Weekly protocol 5 mg once weekly 0.375 mL 37.5 u 8 doses
Daily protocol 1 mg 5× weekly (5 on, 2 off) 0.075 mL 7.5 u 40 doses
Please read this. These numbers come from published research. They are here as reference, not as instructions. A lot of them come from lab studies rather than studies in people, and some of these peptides have never been given to a person at all.

About MOTS-c

Mitochondrial
Also known as
Mitochondrial ORF of the 12S rRNA type-c
Class
Mitochondrial
Route
Subcutaneous
Half-life
Short
Evidence tier
Preclinical

A mitochondrial-derived peptide acting via AMPK on insulin sensitivity and metabolic homeostasis. Genuinely interesting mechanism with solid research data and human observational correlations, but no human dosing trials.

Buy MOTS-c

Common Questions — MOTS-c

How much bacteriostatic water do I add to a 10 mg vial of MOTS-c?

Adding 2 mL of bacteriostatic water to a 10 mg vial gives 5 mg/mL. That is the mix every number on this page is worked out from — change the water figure in the calculator and all the draw amounts update.

What dose of MOTS-c is used in research?

Published and reported figures for MOTS-c on these protocols are 5 mg once weekly, or 1 mg a day on a five-days-on two-days-off pattern. This site lists each figure with the source it came from rather than giving a single recommended number.

How many units on the syringe is a 5 mg dose of MOTS-c?

At 5 mg/mL, a 5 mg dose is 100 units on a 1 mL U-100 insulin syringe. One vial at that mix gives about 2 doses.

How strong is the evidence behind these MOTS-c doses?

MOTS-c is graded preclinical. Laboratory and animal data only. No human dosing trials have been published. We grade every compound on this site so you can weigh the numbers accordingly — the full method is on our editorial policy page.

Where These Numbers Come From

Preclinical — Preclinical and in-vitro data only — no human dosing trials
The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance Lee C, et al. Cell Metabolism, 2015
The discovery paper; source of all research dosing figures.
Find on PubMed ↗
MOTS-c in exercise and skeletal muscle adaptation Reynolds JC, et al. Nature Communications, 2021
Extends the mechanism to exercise capacity and healthspan in preclinical models.
Find on PubMed ↗

Newest Studies —

Not reviewed by us. This list is pulled straight from Europe PMC as papers are published. Nobody has checked whether these are any good, or whether they change anything above. The dose numbers on this page only ever change after a person reviews the evidence.

Need this on one page to print, screenshot or send?

Make a dose card →

Other mitochondrial peptides

Compounds in the same class, or browse the full catalogue.

Glutathione

The principal endogenous intracellular antioxidant tripeptide. Widely administered in clinical settings; the evidence for parenter…

NAD+

A coenzyme rather than a peptide. Direct NAD+ administration is bioavailability-limited and often poorly tolerated (stinging, flus…

All 72 peptides

Every compound compared in one table: dose range, how often, half-life and evidence tier.